Interpreting Randomized Controlled Trials.

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Causal Inference

Background:

• Randomized controlled trials (RCTs) are a cornerstone of clinical research, but their sampling methods present challenges for generalizability.
• Patients in RCTs are typically accrued sequentially, forming a convenience sample rather than a true random sample of a target population.

Purpose of the Study:

• To critically examine the rationales and limitations of making inferences from randomized controlled trial (RCT) data.
• To differentiate between random allocation within an RCT and random sampling for population representation.
• To clarify fundamental concepts crucial for interpreting RCTs and advancing data science.

Main Methods:

• Analysis of randomization procedures in clinical trials.
• Use of causal diagrams to illustrate sampling and allocation differences.
• Conceptual clarification of key dichotomies in research methodology and interpretation (e.g., internal vs. external validity).

Main Results:

• RCT samples are convenience samples, limiting direct inference to broader patient populations.
• Group-specific statistics from RCTs have restricted meaning as population parameters.
• Random allocation within RCTs supports valid comparative causal inferences about treatment effects, assuming transportability.

Conclusions:

• While RCTs may not yield representative samples for general population estimates, their internal validity allows for robust comparisons between interventions.
• The transportability of findings from RCT convenience samples to target populations is a critical assumption for external validity.
• Understanding the distinctions between sampling, allocation, and inference is essential for accurate interpretation of clinical trial data.